Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats

The number of children suffered from autism spectrum disorder (ASD) is increasing dramatically. However, the etiology of ASD is not well known. This study employed mammalian target of rapamycin inhibitor rapamycin to explore its effect on ASD and provided new therapeutic strategies for ASD. ASD rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jie, Liu, Li-Ming, Ni, Jin-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365326/
https://www.ncbi.nlm.nih.gov/pubmed/28360521
http://dx.doi.org/10.2147/NDT.S125088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365326/
https://www.ncbi.nlm.nih.gov/pubmed/28360521
http://dx.doi.org/10.2147/NDT.S125088

Ejemplares similares